IBDEI0J5 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8900,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8900,1,3,0)
 ;;=3^Chr Angle-Closure Glaucoma,Bilateral,Moderate Stage
 ;;^UTILITY(U,$J,358.3,8900,1,4,0)
 ;;=4^H40.2232
 ;;^UTILITY(U,$J,358.3,8900,2)
 ;;=^5005833
 ;;^UTILITY(U,$J,358.3,8901,0)
 ;;=H40.2233^^41^469^17
 ;;^UTILITY(U,$J,358.3,8901,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8901,1,3,0)
 ;;=3^Chr Angle-Closure Glaucoma,Bilateral,Severe Stage
 ;;^UTILITY(U,$J,358.3,8901,1,4,0)
 ;;=4^H40.2233
 ;;^UTILITY(U,$J,358.3,8901,2)
 ;;=^5005834
 ;;^UTILITY(U,$J,358.3,8902,0)
 ;;=H40.2234^^41^469^14
 ;;^UTILITY(U,$J,358.3,8902,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8902,1,3,0)
 ;;=3^Chr Angle-Closure Glaucoma,Bilateral,Indeterminate Stage
 ;;^UTILITY(U,$J,358.3,8902,1,4,0)
 ;;=4^H40.2234
 ;;^UTILITY(U,$J,358.3,8902,2)
 ;;=^5005835
 ;;^UTILITY(U,$J,358.3,8903,0)
 ;;=H40.241^^41^469^115
 ;;^UTILITY(U,$J,358.3,8903,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8903,1,3,0)
 ;;=3^Residual Stage Angle-Closure Glaucoma,Right Eye
 ;;^UTILITY(U,$J,358.3,8903,1,4,0)
 ;;=4^H40.241
 ;;^UTILITY(U,$J,358.3,8903,2)
 ;;=^5005843
 ;;^UTILITY(U,$J,358.3,8904,0)
 ;;=H40.242^^41^469^114
 ;;^UTILITY(U,$J,358.3,8904,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8904,1,3,0)
 ;;=3^Residual Stage Angle-Closure Glaucoma,Left Eye
 ;;^UTILITY(U,$J,358.3,8904,1,4,0)
 ;;=4^H40.242
 ;;^UTILITY(U,$J,358.3,8904,2)
 ;;=^5005844
 ;;^UTILITY(U,$J,358.3,8905,0)
 ;;=H40.61X0^^41^469^43
 ;;^UTILITY(U,$J,358.3,8905,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8905,1,3,0)
 ;;=3^Drug-Induced Glaucoma,Right Eye,Unspec Stage
 ;;^UTILITY(U,$J,358.3,8905,1,4,0)
 ;;=4^H40.61X0
 ;;^UTILITY(U,$J,358.3,8905,2)
 ;;=^5005906
 ;;^UTILITY(U,$J,358.3,8906,0)
 ;;=H40.61X2^^41^469^41
 ;;^UTILITY(U,$J,358.3,8906,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8906,1,3,0)
 ;;=3^Drug-Induced Glaucoma,Right Eye,Moderate Stage
 ;;^UTILITY(U,$J,358.3,8906,1,4,0)
 ;;=4^H40.61X2
 ;;^UTILITY(U,$J,358.3,8906,2)
 ;;=^5005908
 ;;^UTILITY(U,$J,358.3,8907,0)
 ;;=H40.61X3^^41^469^42
 ;;^UTILITY(U,$J,358.3,8907,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8907,1,3,0)
 ;;=3^Drug-Induced Glaucoma,Right Eye,Severe Stage
 ;;^UTILITY(U,$J,358.3,8907,1,4,0)
 ;;=4^H40.61X3
 ;;^UTILITY(U,$J,358.3,8907,2)
 ;;=^5133509
 ;;^UTILITY(U,$J,358.3,8908,0)
 ;;=H40.61X4^^41^469^39
 ;;^UTILITY(U,$J,358.3,8908,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8908,1,3,0)
 ;;=3^Drug-Induced Glaucoma,Right Eye,Indeterminate Stage
 ;;^UTILITY(U,$J,358.3,8908,1,4,0)
 ;;=4^H40.61X4
 ;;^UTILITY(U,$J,358.3,8908,2)
 ;;=^5005909
 ;;^UTILITY(U,$J,358.3,8909,0)
 ;;=H40.62X1^^41^469^35
 ;;^UTILITY(U,$J,358.3,8909,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8909,1,3,0)
 ;;=3^Drug-Induced Glaucoma,Left Eye,Mild Stage
 ;;^UTILITY(U,$J,358.3,8909,1,4,0)
 ;;=4^H40.62X1
 ;;^UTILITY(U,$J,358.3,8909,2)
 ;;=^5005911
 ;;^UTILITY(U,$J,358.3,8910,0)
 ;;=H40.62X0^^41^469^38
 ;;^UTILITY(U,$J,358.3,8910,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8910,1,3,0)
 ;;=3^Drug-Induced Glaucoma,Left Eye,Unspec Stage
 ;;^UTILITY(U,$J,358.3,8910,1,4,0)
 ;;=4^H40.62X0
 ;;^UTILITY(U,$J,358.3,8910,2)
 ;;=^5005910
 ;;^UTILITY(U,$J,358.3,8911,0)
 ;;=H40.62X2^^41^469^36
 ;;^UTILITY(U,$J,358.3,8911,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8911,1,3,0)
 ;;=3^Drug-Induced Glaucoma,Left Eye,Moderate Stage
 ;;^UTILITY(U,$J,358.3,8911,1,4,0)
 ;;=4^H40.62X2
 ;;^UTILITY(U,$J,358.3,8911,2)
 ;;=^5005912
 ;;^UTILITY(U,$J,358.3,8912,0)
 ;;=H40.62X3^^41^469^37
 ;;^UTILITY(U,$J,358.3,8912,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8912,1,3,0)
 ;;=3^Drug-Induced Glaucoma,Left Eye,Severe Stage
